RxDoctor Payments Data

Christopher Toomey

Ophthalmology · San Diego, CANPI 1578922092

Payments from drug & device makers

$77,508in general payments, 2019–2025

Across 18 payments — averaging $4305.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$75K
  • Alnylam Pharmaceuticals Inc.$2K
  • Alcon$145
  • AbbVie$125
  • Apellis Pharmaceuticals, Inc.$29
  • Oyster Point Pharma, Inc.$25
  • plus $44 from 2 others

What the payments were for

  • Consulting fees$2,1403%
  • Grants$75,00097%
  • Food & beverage$3680%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$77,508 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California

Medicare billing

Part B allowed, 2024
$334,511
Medicare patients
185
Services billed
4,352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine11$526
Prednisolone Acetate11$370
Latanoprost18$232

Paid to pharmacies, not to this prescriber.

Other ophthalmology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →